Beijing Keymed Biosciences Co., Ltd. clinical trials

A subsidiary of Keymed Biosciences Co.Ltd

The registry lists 3 studies whose lead sponsor is Beijing Keymed Biosciences Co., Ltd.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.

Status

Not yet recruiting: 2
Completed: 1

Phase

Phase 2: 2
Phase 3: 1

Where

China: 3

Registry sponsor names on this page

Beijing Keymed Biosciences Co., Ltd.3 studies

Something wrong with this grouping? Tell us on the Keymed Biosciences Co.Ltd page.

Studies

Recruiting first, then most recently updated. Showing 3 of 3. All Keymed Biosciences Co.Ltd studies →

Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background TherapyNot yet recruitingNCT07890350Phase 2
Sponsor listed in the registry: Beijing Keymed Biosciences Co., Ltd.
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-3)Not yet recruitingNCT07807826Phase 3
Sponsor listed in the registry: Beijing Keymed Biosciences Co., Ltd.
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1）CompletedNCT06930612Phase 2
Sponsor listed in the registry: Beijing Keymed Biosciences Co., Ltd.